Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures
Kelly R. Barnett(St. Jude Children's Research Hospital), Daniel Savic(St. Jude Children's Research Hospital), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Christopher S. Manring, Ching‐Hon Pui(St. Jude Children's Research Hospital), Brennan P. Bergeron(St. Jude Children's Research Hospital), Robert J. Mobley(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Wenjian Yang(St. Jude Children's Research Hospital), Sima Jeha(St. Jude Children's Research Hospital), Mary V. Relling(St. Jude Children's Research Hospital), Jonathan D. Diedrich(The Barbara Ann Karmanos Cancer Institute), Charles G. Mullighan(St. Jude Children's Research Hospital), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Jun J. Yang(St. Jude Children's Research Hospital), Kashi Raj Bhattarai(Pharmaceutical Biotechnology (Czechia)), Hiroto Inaba(St. Jude Children's Research Hospital), Elisabeth Paietta(Montefiore Medical Center), Mark R. Litzow(Mayo Clinic in Arizona), Kristine R. Crews(St. Jude Children's Research Hospital), Wendy Stock(University of Chicago)
Cited by 3
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k